Effects of covariate omission and categorization when analysing randomized trials with the Cox model

Statistics in Medicine

Volumn 16, Issue 1-3, 1997, Pages 225-237

  Schmoor, Claudia ^a   Schumacher, Martin ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACCURACY; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; COVARIANCE; MAXIMUM LIKELIHOOD METHOD; NONBIOLOGICAL MODEL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; SURVIVAL; TREATMENT OUTCOME; VARIANCE;

EID: 0031022551     PISSN: 02776715     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1097-0258(19970215)16:3<225::aid-sim482>3.0.co;2-c     Document Type: Conference Paper

References (24)

1. Cox, D. R. 'Regression models and life tables (with discussion)', Journal of the Royal Statistical Society, Series B, 34, 187-220 (1972).
2. Vach, W. Logistic Regression with Missing Values in the Covariates, Lecture Notes in Statistics, Springer-Verlag, New York, 1994.
3. Ulm, K., Schmoor, C., Sauerbrei, W., Kemmler, G., Aydemir, Ü., Müller, B. and Schumacher, M. 'Strategien zur Auswertung einer Therapiestudie mit der Überlebenszeit als Zielkriterium', Biometrie und Informatik in Medizin und Biologie, 20, 171-205 (1989).
4. Vach, W. 'Some issues in estimating the effect of prognostic factors from incomplete covariate data', Statistics in Medicine, 16, 57-72 (1997).
5. Rauschecker, H. F., Sauer, R., Schauer, A., Schumacher, M., Olschewski, M., Sauerbrei, W. and Schmoor, C. for the German Breast Cancer Study Group (GBSG). 'Therapy of small breast cancer -Four-year results of a prospective non-randomized study', Breast Cancer Research and Treatment, 34, 1-13 (1995).
6. Cochran, W. G. 'Analysis of covariance: its nature and uses', Biometrics, 13, 261-281 (1957).
7. Schumacher, M., Bastert, G., Bojar, H., Hübner, K., Olschewski, M., Sauerbrei, W., Schmoor, C., Beyerle, C., Neumann, R. L. A. and Rauschecker, H. F. for the German Breast Cancer Study Group (GBSG). 'Randomized 2 x 2 trial evaluating hormonal treatment and the duration of chemotherapy in node-positive breast cancer patients', Journal of Clinical Oncology, 12, 2086-2093 (1994).
8. Schumacher, M., Olschewski, M. and Schmoor, C. 'The impact of heterogeneity on the comparison of survival times', Statistics in Medicine, 6, 773-784 (1987).
9. Gail, M. H., Wieand, S. and Piantadosi, S. 'Biased estimates of treatment effects in randomized experiments with nonlinear regressions and omitted covariates', Biometrika, 71, 431-444 (1984).
10. Struthers, C. A. and Kalbfleisch, J. D. 'Misspecified proportional hazard models', Biometrika, 73, 363-369 (1986).
11. Schmoor, C. and Schumacher, M. 'Misspecification of covariates in the proportional hazards model and its impact on the estimation of treatment effects', Submitted (1995).
12. Andersen, P. K., Borgan, Ø., Gill, R. D. and Keiding, N. Statistical Models Based on Counting Processes, Springer-Verlag, New York, 1993.
13. Keiding, N., Andersen, P. K. and Klein, J. P. The role of frailty models and accelerated failure time models in describing heterogeneity due to omitted covariates', Statistics in Medicine, 16, 215-224 (1997).
14. Wolfram, S. Mathematica: A System for Doing Mathematics by Computer, 2nd edn, Addison-Wesley Publishing Company, Redwood City, California, 1991.
15. Chastang, C., Byar, D. and Piantadosi, S. 'A quantitative study of the bias in estimating the treatment effect caused by omitting a balanced covariate in survival models', Statistics in Medicine, 7, 1243-1255 (1988).
16. Lagakos, S. W. and Schoenfeld, D. A. 'Properties of proportional-hazards score tests under misspecified regression models', Biometrics, 40, 1037-1048 (1984).
17. Morgan, T. M. 'Omitting covariates from the proportional hazards model', Biometrics, 42, 993-995 (1986).
18. Palta, M. and Amini, S. B. 'Consideration of covariates and stratification in sample size determination for survival time studies', Journal of Chronic Diseases, 38, 801-809 (1985).
19. Beach, M. L. and Meier, P. 'Choosing covariates in the analysis of clinical trials', Controlled Clinical Trials, 10, 161S-175S (1989).
20. Robinson, L. D. and Jewell, N. P. 'Some surprising results about covariate adjustment in logistic regression models', International Statistical Review, 59, 227-240 (1991).
21. Morgan, T. M. and Elashoff, R. M. 'Effect of censoring on adjusting for covariates in comparison of survival times', Communications in Statistics, Part A - Theory and Methods, 15, 1837-1854 (1986).
22. Morgan, T. M. and Elashoff, R. M. 'Effect of categorizing a continuous covariate on the comparison of survival time', Journal of the American Statistical Association, 81, 917-921 (1986).
23. Gail, M. H., Tan, W. Y. and Piantadosi, S. 'Tests for no treatment effect in randomized clinical trials', Biometrika, 75, 57-64 (1988).
24. Lin, D. Y. and Wei, L. J. 'The robust inference for the Cox regression model', Journal of the American Statistical Association, 84, 1074-1078 (1989).